Newsroom

News

Rare diseases affecting fewer than five in 10,000 people are often particularly difficult to diagnose and treat. As part of their joint funding program “zukunft.niedersachsen”, the state of Lower Saxony and the Volkswagen Foundation have now selected nine promising research projects for funding that aim to develop new diagnoses and treatments for rare diseases. Among them are two projects from the Helmholtz Centre for Infection Research (HZI). The PREDICT-CTP consortium of TWINCORE, the HZI, and Hannover Medical School (MHH) is developing a new diagnostic method for rheumatic diseases. In the StopPSC project, researchers from the HZI and MHH are developing new agents to treat primary sclerosing cholangitis, a chronically progressive inflammation of the bile ducts.

22.12.2025

TWINCORE

HZI Campus

News

Experts are increasingly turning to machine learning to predict antibiotic resistance in pathogens. With its help, resistance mechanisms can be identified based on a pathogen’s genetics. However, the results should be viewed with caution: Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg have shown that the models are often less reliable than assumed. Their findings were published in the journal PLOS Biology. They contribute to the development of more reliable tools for predicting and combating antibiotic resistance.

17.12.2025

HIRI

Teaser for the podcast with Andreas Keller

News

At first glance, biology and computer science seem like opposites. But wherever enormous amounts of data are generated from research, progress is hardly possible without digital methods. Bioinformatician Prof. Andreas Keller therefore relies on artificial intelligence. He heads the department “Clinical Bioinformatics” at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). In this episode of InFact, he talks about how AI can help us understand how beneficial and harmful bacteria communicate with each other in our bodies, how to predict when infections will cause long-term effects, and how this can be used to develop new drugs against dangerous pathogens.

16.12.2025

HIPS

News

Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of reach for drug development. The main obstacle was the limited understanding of how these compounds are produced by their microbial hosts. A research team led by Tobias Gulder, department head at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), has now deciphered the biosynthetic pathway of the biphenomycins, establishing the foundation for their pharmaceutical advancement. The team published its findings in the journal Angewandte Chemie International Edition.

11.12.2025

HIPS

Maximilian Order awarded to HIRI Director Jörg Vogel by Marcus Söder

News

On December 3, Jörg Vogel, Director of the Helmholtz Institute for RNA-based Infection Research, was honored with the Maximilian Order for Science and Art at a ceremony held in the Antiquarium of the Munich Residence. He received the distinction from Bavarian Minister-President Markus Söder, who referred to the Free State’s highest honor as the ‘Bavarian Nobel Prize’. HIRI is site of the Braunschweig Helmholtz Centre for Infection Research (HZI) in cooperation with the Julius-Maximilians-Universität Würzburg (JMU).

04.12.2025

HIRI

Story

On 18–20 November 2025, the Central African Republic (CAR) celebrated its first-ever Dzanga-Sangha Day (La Journée des Aires Protégées de Dzanga-Sangha). Conceived as a three-day national event, the celebration aimed to shine a spotlight on the country’s unique natural heritage and raise awareness of the Dzanga-Sangha Protected Areas (DSPA)—an extraordinary conservation landscape in CAR’s remote southwest. Held under the theme “Reconciling Nature, Health and Development”, the event underscored how biodiversity protection, community wellbeing, and scientific research intersect in DSPA. It was co-organized by the Government of the Central African Republic in partnership with WWF and the Helmholtz Institute for One Health (HIOH).

03.12.2025

HIOH

Back to the first page
...
5
6
7
8
...
155

HZI in the media

... sich auch das Helmholtz-Institut für Pharmazeutische Forschung Saarland ( HIPS ), das Helmholtz-Zentrum für Infektionsforschung ( HZI ) ...

09.04.2026

Deutsches Ärzteblatt

... ÖAW in Wien und nun Gruppenleiter am Helmholtz Zentrum für Infektionsforschung in Braunschweig, forscht an ...

08.04.2026

DerStandard.de

... group within the Microstar Program at the Helmholtz Centre for Infection Research (HZI) and a ...

31.03.2026

Informations Dienst Wissenschaft

... an der Medizinischen Hochschule Hannover und am Helmholtz Institut für Infektionen in Braunschweig die Wirkung ...

28.03.2026

Hamburger Abendblatt

led by wildlife veterinarian Fabian Leendertz, who heads the Helmholtz Institute for One Health, took hundreds of samples from meat and

27.03.2026

Science.org

Gesellschaft. Apropos Standort Braunschweig: Auch das Helmholtz-Zentrum für Infektionsforschung HZI, in dessen Räumlichkeiten auf dem ...

27.03.2026

transkript

Helmholtz Centre for Infection Research

After infection with SARS-CoV-2, up to 10 percent of people in Germany go on to develop Long COVID.

26.03.2026

Mirage.News

... von verschiedenen Hörnchen, wie jüngste Erkenntnisse des Helmholtz Instituts für One Health in Greifswald kürzlich ...

26.03.2026

Tagesschau

zur Bekämpfung der Tuberkulose und des Helmholtz-Zentrums für Infektionsforschung erstellt. Zahlreiche weitere Fachgesellschaften und

24.03.2026

Deutsches Ärzteblatt

... fünf Teams durch, darunter PROTON vom Helmholtz-Zentrum für Infektionsforschung. Dieses entwickelt einen neuartigen Wirkstoff gegen ...

22.03.2026

Ad Hoc News

Vor allem durch die Coronapandemie sind Forschende des Helmholtz-Zentrums für Infektionsforschung in den vergangenen Jahren bundesweit bekannt geworden. Auf welche Themen die Einrichtung für die Zukunft setzt.

20.03.2026

Deutsches Ärzteblatt

... beschäftigt sich daneben unter dem Dach des Helmholtz Institutes für Pharmazeutische Forschung Saarland (HIPS) ...

18.03.2026

Biermann Medizin

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.